Anti-Thyrotropin Autoantibodies in Patients with Macro-Thyrotropin and Long-Term Changes in Macro-Thyrotropin and Serum Thyrotropin Levels
Authors:
- 1 February 2017
- journal article
- research article
- Published by SAGE Publications in Thyroid®
- Vol. 27 (2) , 138-146
Abstract
Background: Macro-thyrotropin (TSH) is a high-molecular-weight form of TSH. Most cases of macro-TSH are TSH complexed with immunoglobulin G. This study was undertaken to characterize macro-TSH. Methods: Blood samples taken from patients with subclinical hypothyroidism were screened for the presence of macro-TSH with the polyethylene glycol method and confirmed with gel filtration chromatography. TSH receptor antibody was quantified with an electrochemiluminescence immunoassay. Binding studies were performed using 125 I-human TSH, and the specificity of anti-TSH autoantibodies was tested by displacement experiments using excess amounts of the unlabeled related peptides. Macro-TSH and serum TSH levels were evaluated twice over a one- to four-year interval. Results: Sixteen patients (11 females and 5 males; aged 8–82 years) were diagnosed as having macro-TSH. None of the patients with macro-TSH tested positive for TSH receptor antibody. Judging from the affinity and the binding capacity of anti-TSH autoantibodies, two classes of binding sites were identified. Regarding specificity, there were anti-human TSH-β autoantibodies that were partially cross-reactive to bovine and/or rat TSH-β. There were also autoantibodies against human glycoprotein α, a common subunit among human TSH, luteinizing hormone, and follicle stimulating hormone. Macro-TSH persisted in 11/13 patients who could be reevaluated over a one- to four-year interval after the first evaluation. Serum TSH levels returned to normal in the remaining two patients whose macro-TSH disappeared. Conclusions: It is concluded that anti-human TSH autoantibodies are a major cause of macro-TSH and that macro-TSH may persist for a long time.Keywords
This publication has 24 references indexed in Scilit:
- An immunoglobulin G complexed form of thyroid-stimulating hormone (macro thyroid-stimulating hormone) is a cause of elevated serum thyroid-stimulating hormone concentrationAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2013
- Elevated thyroid‐stimulating hormone level in a euthyroid neonate caused by macro thyrotropin–IgG complexActa Paediatrica, 2011
- Macro Thyrotropin-IgG Complex Causes Factitious Increases in Thyroid-Stimulating Hormone Screening Tests in a Neonate and MotherClinical Chemistry, 2006
- Clinical relevance of macroprolactinClinical Endocrinology, 2005
- ANTI‐TSH ANTIBODY WITH HIGH SPECIFICITY TO HUMAN TSH IN SERA FROM A PATIENT WITH GRAVES' DISEASE: ITS ISOLATION FROM, AND INTERACTION WITH, TSH RECEPTOR ANTIBODIESClinical Endocrinology, 1987
- AUTOANTIBODY TO BOVINE TSH IN HASHIMOTO'S THYROIDITISThe Lancet, 1984
- Transient neonatal hyperthyrotrophinaemia: a serum abnormality due to transplacentally acquired antibody to thyroid stimulating hormone.BMJ, 1983
- Binding of 125I-human TSH by gamma globulins of sera containing thyroid-stimulating immunoglobulin (TSI)Life Sciences, 1983
- SPECIFIC BINDING OF THYROID-STIMULATING HORMONE BY HUMAN SERUM GLOBULINSJournal of Endocrinology, 1981
- Increased High-Molecular-Weight Thyrotropin with Impaired Biologic Activity in a Euthyroid ManNew England Journal of Medicine, 1981